Lv31
400 积分 2023-03-15 加入
Breast cancer statistics 2024
12天前
已完结
Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis
14天前
已完结
Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: a Bayesian network meta-regression analysis
16天前
已完结
Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis
16天前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
19天前
已完结
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
19天前
已完结
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67
19天前
已完结
Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial
21天前
已完结
Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial
21天前
已关闭
Improving pathological response in locally advanced triple negative breast cancer: Comparison between CbD and AC-T regimens
2个月前
已关闭
皖公网安备34019202002308
